Quantitative mechanistically based dose-response modeling with endocrine-active compounds

被引:15
作者
Andersen, ME
Conolly, RB
Faustman, EM
Kavlock, RJ
Portier, CJ
Sheehan, DM
Wier, PJ
Ziese, L
机构
[1] Colorado State Univ, Dept Environm Hlth, Ft Collins, CO 80523 USA
[2] Chem Ind Inst Toxicol, Res Triangle Pk, NC 27709 USA
[3] Univ Washington, Dept Environm Hlth, Seattle, WA 98195 USA
[4] US EPA, Natl Hlth & Environm Effects Res Labs, Res Triangle Pk, NC 27711 USA
[5] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA
[6] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA
[7] SmithKline Beecham Pharmaceut, King Of Prussia, PA 19406 USA
[8] Calif Protect Agcy, RCHAS, Off Environm Hlth Hazard Assoc, Berkeley, CA USA
关键词
endocrine-active compounds; endocrine disruptors; linkage models mechanistic dose-response modeling; pharmacodynamics; pharmacokinetics; risk assessment extrapolations;
D O I
10.2307/3434556
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
A wide range of toxicity lest methods is used or is being developed for assessing the impact of endocrine-active compounds (EACs) on human hearth. Interpretation of these data and their quantitative use in human and ecologic risk assessment will be enhanced by the availability of mechanistically based dose-response (MBDR) models to assist tow-dose, interspecies, and in vitro to in vivo extrapolations. A quantitative dose-response modeling work group examined the state of the art for developing MBDR models for EACs and the near-term needs to develop, validate, and apply these models for risk assessments. Major aspects of this report relate to current status of these models, the objectives/goals in MBDR model development for EACs, low-dose extrapolation issues, regulatory inertia impeding acceptance of these approaches, and resource/data needs to accelerate model development and model acceptance by the research and the regulatory community.
引用
收藏
页码:631 / 638
页数:8
相关论文
共 55 条
[1]   DOSE-RESPONSE ASSESSMENT FOR DEVELOPMENTAL TOXICITY .3. STATISTICAL-MODELS [J].
ALLEN, BC ;
KAVLOCK, RJ ;
KIMMEL, CA ;
FAUSTMAN, EM .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1994, 23 (04) :496-509
[2]   DOSE-RESPONSE ASSESSMENT FOR DEVELOPMENTAL TOXICITY .2. COMPARISON OF GENERIC BENCHMARK DOSE ESTIMATES WITH NO OBSERVED ADVERSE EFFECT LEVELS [J].
ALLEN, BC ;
KAVLOCK, RJ ;
KIMMEL, CA ;
FAUSTMAN, EM .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1994, 23 (04) :487-495
[3]  
Andersen M.E., 1998, TRIAZINE HERBICIDES, P432
[4]   PHYSIOLOGICALLY BASED PHARMACOKINETICS AND THE RISK ASSESSMENT PROCESS FOR METHYLENE-CHLORIDE [J].
ANDERSEN, ME ;
CLEWELL, HJ ;
GARGAS, ML ;
SMITH, FA ;
REITZ, RH .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 87 (02) :185-205
[5]   Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin evaluated with a multicompartment geometric model of hepatic zonation [J].
Andersen, ME ;
Birnbaum, LS ;
Barton, HA ;
Eklund, CR .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 144 (01) :145-155
[6]   MODELING RECEPTOR-MEDIATED PROCESSES WITH DIOXIN - IMPLICATIONS FOR PHARMACOKINETICS AND RISK ASSESSMENT [J].
ANDERSEN, ME ;
MILLS, JJ ;
GARGAS, ML ;
KEDDERIS, L ;
BIRNBAUM, LS ;
NEUBERT, D ;
GREENLEE, WF .
RISK ANALYSIS, 1993, 13 (01) :25-36
[7]   APPLYING SIMULATION MODELING TO PROBLEMS IN TOXICOLOGY AND RISK ASSESSMENT - A SHORT PERSPECTIVE [J].
ANDERSEN, ME ;
CLEWELL, HJ ;
FREDERICK, CB .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 133 (02) :181-187
[8]  
Andersen ME, 1997, J TOXICOL ENV HEALTH, V52, P189, DOI 10.1080/009841097159656
[9]   Biological regulation of receptor-hormone complex concentrations in relation to dose-response assessments for endocrine-active compounds [J].
Andersen, ME ;
Barton, HA .
TOXICOLOGICAL SCIENCES, 1999, 48 (01) :38-50
[10]   A model for pharmacokinetics and physiological feedback among hormones of the testicular-pituitary axis in adult male rats: A framework for evaluating effects of endocrine active compounds [J].
Barton, HA ;
Andersen, ME .
TOXICOLOGICAL SCIENCES, 1998, 45 (02) :174-187